enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
/PRNewswire/ - enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral, intravesical lead...
Stay updated with breaking news from Board Additions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral, intravesical lead...
Pivotal phase 2 LEGEND study of EG-70 in BCG-unresponsive non-muscle invasive bladder cancer remains on track with interim data anticipated in mid-2024 Closed a $200 million oversubscribed private...
Town chairman David Sheepshanks has revealed that there will be additions to the club's board in the near future. However, the £200,000 share investor, whose identity currently remains a mystery, does not want to become a director.